Statement of Chair Lina M. Khan on the Ruling by Judge Denise L.
Jan 14, 2022 · Federal Trade Commission Chair Lina Khan issued the following statement regarding today’s decision: “Judge Cote’s decision to ban Shkreli for life from the pharmaceutical industry is a significant victory for American consumers.
Martin Shkreli - Wikipedia
Martin Shkreli (/ ˈʃkrɛli /; born March 17, 1983) is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel ...
Lifelong industry ban for ‘Pharma Bro’ who inflated HIV drug cost
Martin Shkreli, 38, will have to pay $64.6 million for violating antitrust laws, monopolizing access to the drug Daraprim through restrictive distribution contracts and cutting off generic drug …
Shkreli was remanded to federal custody on September 13, 2017. He is currently scheduled to be released on October 11, 2023, or one year earlier pending successful completion of an early release program.
The US District Court for the Southern District of New York holds a ...
Today, U.S. District Court Judge Denise Cote held “Pharma Bro” Martin Shkreli liable for antitrust claims brought by the Federal Trade Commission and a group of seven state enforcers.
Shkreli’s infamous price-gouging scheme finally shut down in …
Dec 9, 2021 · A pharmaceutical company once owned by Martin Shkreli will pay up to $40 million in a settlement that will also finally end his infamous price-gouging scheme involving the antiparasitic drug...
High Drug Prices Sparked Outrage But Little Action : Shots
Dec 31, 2019 · After hiking the price of an old drug for parasitic infections to $750 a pill from $13.50, Shkreli became the poster boy for pharmaceutical greed that helped define the past decade.
‘Pharma Bro’ firm reaches $40 million settlement as Shkreli …
Dec 8, 2021 · Martin Shkreli, best known for drug price-gouging and a snarky online persona, still faces an antitrust trial over his alleged role in masterminding a plot to jack up prices for life-saving drug...
Martin Shkreli can't escape his $64 million fine - Yahoo
Oct 7, 2024 · The U.S. Supreme Court decided on Monday not to take up Martin Shkreli’s appeal of a $64.6 million penalty he received after raising the price of a lifesaving drug by more than 4,000% during...
'Pharma Bro' fraudster Martin Shkreli handed lifetime ban from …
Jan 14, 2022 · WASHINGTON — A U.S. judge on Friday barred Martin Shkreli from the pharmaceutical industry for life and ordered him to pay $64.6 million after he famously raised the price of the drug Daraprim...